INSILICO MEDICINE
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digita... l medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.
INSILICO MEDICINE
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Hong Kong, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.insilico.com
Total Employee:
101+
Status:
Active
Total Funding:
401.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Euro COVID-19
Similar Organizations
3billion
3billion is a world leader in the field of genetic diagnostics for rare disease.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Advisor
2014-01-01
Board_member
Board_member
Advisor
2016-04-01
Current Employees Featured
Alex Zhavoronkov Founder & Chief Executive Officer @ Insilico Medicine
Founder & Chief Executive Officer
2014-03-01
Qingsong Zhu COO @ Insilico Medicine
COO
2014-01-01
Michelle Chen Chief Business Officer @ Insilico Medicine
Chief Business Officer
2021-10-01
Robert Spiegel Chief Medical Officer @ Insilico Medicine
Chief Medical Officer
2021-09-01
Alex Aliper President of EMEA @ Insilico Medicine
President of EMEA
2015-12-01
Vladimir Naumov bioinformatics data scientist @ Insilico Medicine
bioinformatics data scientist
2020-04-01
Nirav Jhaveri Chief Financial Officer @ Insilico Medicine
Chief Financial Officer
2021-01-01
Feng Ren co-CEO @ Insilico Medicine
co-CEO
2022-06-01
Polina Mamoshina Research Scientist @ Insilico Medicine
Research Scientist
Founder
Investors List
B Capital Group
B Capital Group investment in Series D - Insilico Medicine
BHR Partners
BHR Partners investment in Series D - Insilico Medicine
Prosperity7 Ventures
Prosperity7 Ventures investment in Series D - Insilico Medicine
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati investment in Series D - Insilico Medicine
Deerfield
Deerfield investment in Series D - Insilico Medicine
Pavilion Capital
Pavilion Capital investment in Series D - Insilico Medicine
Warburg Pincus
Warburg Pincus investment in Series D - Insilico Medicine
Qiming Venture Partners
Qiming Venture Partners investment in Series D - Insilico Medicine
Bold Capital Partners
Bold Capital Partners investment in Series D - Insilico Medicine
Bold Capital Partners
Bold Capital Partners investment in Series D - Insilico Medicine
Newest Events participated
Participated in Women in AI in Healthcare Dinner, London 2017
on 2017-11-22 as sponsor
Key Employee Changes
Official Site Inspections
http://www.insilico.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.88 K
- Host name: 185.215.4.66
- IP address: 185.215.4.66
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Insilico Medicine"
Insilico Medicine - Wikipedia
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. See details»
Insilico - Crunchbase Company Profile & Funding
Insilico is a company that provides new material development and system construction services with a new high-efficiency/low-cost methodology based on IT and material convergence technology. The company also provides …See details»
Team | Insilico Medicine
Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in generative artificial intelligence technologies for drug discovery and biomarker development.Dr. Zhavoronkov has a combined …See details»
Insilico Medicine - Crunchbase Company Profile
Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life …See details»
Mission | Insilico Medicine
The company's team is distributed globally, allowing the company to establish a local presence in key geographies, with office sites or R&D talents in the U.S., Greater China, Canada, and the Middle East to support recruitment of top …See details»
InSilico Medicine Company Profile 2025: Valuation, …
InSilico Medicine General Information Description. Researcher and developer of an artificial intelligence (AI) platform and new drugs designed to deliver breakthrough solutions for cancer, fibrosis, immunity, central nervous system …See details»
Insilico Medicine | World Economic Forum
Dec 20, 2023 The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to shape global, …See details»
Insilico Medicine - Overview, News & Similar companies - ZoomInfo
May 30, 2024 Insilico developed a PaperGPT system based on ChatGPT-4 Turbo and internal LLM that provides answers related to the paper via chat functionality. NEW YORK and HONG …See details»
insilicogroup.com – Innovate, Scale & Thrive
With an unwavering commitment to excellence, InSilico stands ready to redefine possibilities and empower businesses for a prosperous future. 01 Tech-Driven Business Strategy. 02 Mobile …See details»
Insilico Medicine Company Profile: AI, Investments, Contact …
Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company …See details»
Insilico Medicine - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
InSilico Medicine Company Profile - Office Locations ... - Craft
InSilico Medicine Hong Kong is a technology company that develops AI-based platforms for drug development and discovery. It provides Pharma.AI, a drug discovery engine that utilizes data …See details»
Insilico - Lab Manager
As a result, Insilco’s unique approach substantially reduces experimental effort, costs of goods and time to market. Leading biopharmaceutical companies worldwide use Insilico digital twins …See details»
Working At Insilico Medicine: Company Overview and Culture
Mar 14, 2024 Insilico Medicine, an artificial intelligence company headquartered in Rockville, MD, pioneered the applications of the generative adversarial networks (GANs), reinforcement …See details»
Insilico Medicine launches a 6th generation Intelligent Robotics …
Jan 5, 2023 Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – a 6th generation Intelligent …See details»
20 Things You Didn’t Know About Insilico Medicine - Money Inc
Oct 13, 2021 NVIDIA named Insilico to its list of the top five artificial intelligence companies in 2017. The organization cited that Insilico has a tremendous potential to make a positive social …See details»
Insilico's AI-Designed Drug ISM5411 Shows Promise
14 hours ago CAMBRIDGE, Massachusetts, Jan 7, 2024 — Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development …See details»
Chemistry42 - Insilico
Chemistry42 is a comprehensive small molecules drug discovery platform. It streamlines hit identification, hit-to-lead, and lead optimization programs.See details»
Press Releases | Insilico Medicine
Jan 10, 2023 1250 René-Lévesque Ouest, Suite 3710, Montréal, Québec, Canada H3B 4W8See details»
Insilico Reports Promising Topline Results from Two Phase 1 Trials of
13 hours ago Insilico Medicine, a trailblazer in the realm of artificial intelligence (AI)-driven drug discovery, has announced promising outcomes from two Phase I clinical trials of ISM5411, a …See details»